CTRI/2022/07/043789
Completed
Phase 4
A post market clinical follow up prospective study to evaluate safety and performance of Eye Preparations (Hypromellose 0.3% w/v Sodium Hyaluronate 0.1% w/v Eye Drops).
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Health Condition 1: H28- Cataract in diseases classified elsewhere
- Sponsor
- STERICON PHARMA PRIVATE LIMITED
- Enrollment
- 54
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subjects who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
- •\-Subjects wearing contact lenses who experience dryness, Itchiness, discomfort of eyes due to the continuous use of computer/TV/exposed pollution/dry environment
Exclusion Criteria
- •\-Subjects who are not willing to participate in the study
- •\-Anyone with known allergic reaction to Hypromellose \+Sodium Hyaluronate eye drops
- •\-Subjects with existing eye infection
- •\-Subjects undergone recent (6 weeks) cataract surgery who are on other eye medication
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A post market clinical follow up study of Sterile Hydroxy Propyl Methyl Cellulose Eye DropsHealth Condition 1: H579- Unspecified disorder of eye and adnexaCTRI/2024/02/062930Amanta Healthcare Limited65
Not yet recruiting
Phase 4
A study to evaluate safety and performance of Hydroxypropyl Methylcellulose Eye DropsCTRI/2024/06/069121Kilitch Healthcare India Ltd.
Completed
Phase 4
Study to evaluate safety and performance of Eye Preparations - Carmellose Sodium Eye DropsHealth Condition 1: H28- Cataract in diseases classified elsewhereCTRI/2022/07/043791STERICON PHARMA PRIVATE LIMITED54
Not yet recruiting
Phase 4
A study to evaluate safety and performance of Sodium Hyaluronate Ophthalmic SolutioCTRI/2024/06/068514Kilitch Healthcare India Ltd.
Completed
Phase 4
The purpose of the study is to evaluate safety and performance of Eye Preparations - HPMC EYE WASH (Hydroxy Propyl Methyl Cellulose Eye Wash )Health Condition 1: H28- Cataract in diseases classified elsewhereCTRI/2022/07/043794STERICON PHARMA PRIVATE LIMITED72